Graph AI, a California-based life-sciences startup founded in 2024, has raised $3 million in seed funding led by Bessemer Venture Partners. The capital will fuel its flagship platform, Graph Safety, which automates pharmacovigilance tasks such as adverse-event reporting and compliance. Clients have reported up to 70% efficiency gain and 90% faster regulatory workflows.